SeaStar Medical Holding Corp
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page hereto)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Eric Schlorff his or her true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for him or her and in his or her name, place and stead, in any and all capacities, to execute any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Eric Schlorff | Chief Executive Officer and Director | March 25, 2026 |
| Eric Schlorff | (Principal Executive Officer) | |
| /s/ Michael Messinger | Chief Financial Officer | March 25, 2026 |
| Michael Messinger | (Principal Financial Officer) | |
| /s/ Bradford K. Towne | Controller | March 25, 2026 |
| Bradford K. Towne | (Principal Accounting Officer) | |
| /s/ Jennifer A. Baird | Chairperson of the Board of Directors | March 25, 2026 |
| Jennifer A. Baird | ||
| /s/ John Neuman | Director | March 25, 2026 |
| John Neuman | ||
| /s/ Kenneth Van Heel | Director | March 25, 2026 |
| Kenneth Van Heel | ||
| /s/ Bernadette N. Vincent | Director | March 25, 2026 |
| Bernadette N. Vincent | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.